鲁西化工：6月19日接受机构调研，景顺长城基金参与

Core Viewpoint - The company, Luxi Chemical (000830), is actively managing its production and sales in response to market conditions, while also addressing safety and operational efficiency concerns. The company reported a mixed performance in Q1 2025, with revenue growth but a decline in net profit due to market price fluctuations. Group 1: Production and Operations - The overall production and operational situation of the company is stable, with enhanced safety management measures in place to address seasonal challenges and external safety conditions [2] - The company is focusing on energy conservation, quality improvement, and maximizing economic benefits by adjusting production, sales, and procurement in response to market changes [2] Group 2: Financial Performance - In Q1 2025, the company achieved a revenue of approximately 7.29 billion yuan, representing a year-on-year increase of 7.96%. However, the net profit attributable to shareholders was about 413 million yuan, a decrease of 27.3% year-on-year [3][7] - The net profit excluding non-recurring gains and losses was approximately 384 million yuan, down 33.81% year-on-year, primarily due to a decline in the prices of certain chemical products, which fell more than the decrease in raw material costs [3][7] Group 3: Market Outlook and Strategy - The company anticipates that the market prices of chemical products will fluctuate due to various factors, making predictions challenging. It plans to adjust its strategies in line with market changes to mitigate risks and enhance cost management [6] - The company has signed a framework cooperation agreement with Sinochem Blue Sky to address competition issues related to certain products, indicating a strategic move to streamline operations and enhance market positioning [5] Group 4: Dividend Policy - The company has proposed a cash dividend of 3.50 yuan per 10 shares for the 2024 fiscal year, which has already been implemented. Future dividend policies will be determined based on profitability, cash flow, and regulatory requirements [4] Group 5: Analyst Ratings and Predictions - Over the past 90 days, six institutions have provided ratings for the stock, with five recommending a buy and one recommending an increase. The average target price set by analysts is 13.34 yuan [8] - Detailed profit forecasts for 2025 to 2027 indicate varying net profit estimates from different institutions, reflecting a range of expectations for the company's financial performance in the coming years [9]